Call Us

0162 852 0144

Opening Hours

Click to View

Opening Hours

  • Monday: 8:30am – 6:30pm
  • Tuesday: 8:30am – 6:30pm
  • Wednesday: 8:30am – 6:30pm
  • Thursday: 8:30am – 6:30pm
  • Friday: 8:30am – 6:30pm
  • Saturday: 9am – 5:30pm
  • Sunday: Closed

Choosing Between Mounjaro and Wegovy for Weight Loss

If you’re searching for an effective weight loss treatment, you may have come across two prescription injections: Mounjaro and Wegovy. Both are used to support weight management in people struggling with obesity or overweight conditions, but they work in different ways. At Bourne End Pharmacy, we aim to provide clarity on these treatments so you can make an informed decision. In this guide, we compare Mounjaro vs Wegovy, their mechanisms, effectiveness, side effects, and suitability.

Understanding Mounjaro and Wegovy

Both Mounjaro and Wegovy are medications that help control blood sugar and reduce appetite. They work by mimicking the natural hormone in your body that helps regulate these functions. However, Mounjaro has an extra feature—it also activates another hormone that boosts insulin production and may enhance weight loss even more.

What is Mounjaro?

Mounjaro (tirzepatide) is a relatively new medication originally developed for type 2 diabetes. However, clinical trials have demonstrated its significant weight loss benefits, leading to its use as an obesity treatment. By targeting both GLP-1 and GIP receptors, Mounjaro enhances insulin production, reduces appetite, and slows digestion, promoting weight loss.

What is Wegovy?

Wegovy (semaglutide) is an FDA and MHRA-approved weight loss medication specifically formulated for obesity management. It works by mimicking GLP-1, helping regulate hunger signals, reduce food intake, and improve metabolic function. Wegovy has been widely adopted for weight management and is known for its effectiveness in helping patients achieve long-term weight loss goals.

Compare Mounjaro vs Wegovy for your weight loss journey.

Comparing Mounjaro vs Wegovy

1. Mechanism of Action

Mounjaro: Targets both GLP-1 and GIP receptors, enhancing insulin production, appetite suppression, and digestion regulation.

Wegovy: Acts solely on GLP-1 receptors, reducing appetite and calorie intake.

2. Effectiveness for Weight Loss

Both Mounjaro and Wegovy have been shown to promote significant weight loss in clinical trials:

Mounjaro: Studies show patients may lose up to 22.5% of their body weight over 72 weeks when using Mounjaro.

Wegovy: Clinical trials indicate an average weight loss of around 15% of body weight over a similar period.

3. Dosage and Administration

Mounjaro: Administered as a once-weekly injection, with doses starting at 2.5mg and gradually increasing based on patient response.

Wegovy: Also a once-weekly injection, starting at 0.25mg and increasing to a maintenance dose of 2.4mg.

4. Side Effects

Both medications share some common side effects, including:

  • Nausea
  • Vomiting
  • Diarrhoea or constipation
  • Reduced appetite

However, Mounjaro may cause additional gastrointestinal issues due to its dual action on GLP-1 and GIP receptors, whereas Wegovy may lead to slightly higher nausea rates.

5. Suitability and Eligibility

Both treatments are prescribed for individuals with a BMI of 30 or above or those with a BMI of 27+ and weight-related conditions such as diabetes or hypertension. However:

Mounjaro may be particularly suitable for those with type 2 diabetes and weight concerns.

Wegovy is specifically licensed for weight loss and is an excellent choice for those without diabetes.

6. Cost and Availability

Mounjaro is currently being introduced as a weight loss treatment and may not be as widely available as Wegovy in the UK.

Wegovy is already an established treatment for weight loss and is available through private prescriptions, with increasing availability in pharmacies.

Compare Mounjaro vs Wegovy for weight loss and diabetes.

Which Treatment is Right for You?

The choice between Mounjaro and Wegovy depends on your individual health needs, weight loss goals, and medical history. If you have type 2 diabetes, Mounjaro may be a better option due to its dual-action mechanism. If your primary focus is weight loss, Wegovy is a well-established treatment with a strong success rate. However, if you are looking for more significant weight reduction, clinical trials have shown that Mounjaro leads to a greater percentage of body weight loss.

At Bourne End Pharmacy, we provide expert guidance on weight loss medications and personalised treatment plans. If you are considering prescription weight loss injections, we can help determine the best option for you. Reach out to us today to find out more.

Get Started with Weight Loss Support

If you are struggling with weight management and are looking for effective medical treatment, contact Bourne End Pharmacy today. We can provide expert advice, private prescriptions, and ongoing support to help you achieve your weight loss goals with Mounjaro or Wegovy.

Book a consultation today to discuss your options and take the first step towards a healthier future!

Loading...

This blog was written on behalf of Bourne End Pharmacy by Pharmacy Mentor.